ALV
Autoliv, Inc.
ALV has the edge over LCID overall, supported by lower modeled downside and stronger valuation.
LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
ALV Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
ALV's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ALV PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $119 | — |
| Cheap | 13x | $105 | -12% |
| Current | 14x | $119 | — |
| Fair | 17x | $144 | +21% |
| Expensive | 31x | $262 | +120% |
Historical ranges are pointers, not guarantees.
ALV's PE is in its fair range at 14x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its cheap range.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
ALV Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect ALV's earnings to grow and its profitability to improve, with its revenue holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ALV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.23 | +35% |
| Q3 2026 | $8.33 | -14% |
| Q2 2026 | $8.48 | -6.9% |
| Q1 2026 | $9.29 | +7.3% |
| Q4 2025 | $9.55 | +19% |
| Q3 2025 | $9.65 | +26% |
| Q2 2025 | $9.11 | +22% |
| Q1 2025 | $8.66 | +36% |
| Q4 2024 | $8.04 | +41% |
ALV has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
ALV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.7B | -0.5% |
| Q2 2026 | $2.8B | +3.3% |
| Q1 2026 | $2.8B | +6.8% |
| Q4 2025 | $2.8B | +7.7% |
| Q3 2025 | $2.7B | +5.9% |
| Q2 2025 | $2.7B | +4.2% |
| Q1 2025 | $2.6B | -1.4% |
| Q4 2024 | $2.6B | -4.9% |
ALV's revenue has picked up after two years of holding roughly level: $2.7B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.4% | -0.4 points |
| Q2 2026 | 6.8% | -2.3 points |
| Q1 2026 | 8.6% | -1.2 points |
| Q4 2025 | 11% | -2.2 points |
| Q3 2025 | 9.9% | +1 points |
| Q2 2025 | 9.1% | +1.2 points |
| Q1 2025 | 9.8% | +2.4 points |
| Q4 2024 | 13% | +4.9 points |
ALV has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over ALV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
ALV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $124M | -18% |
| Q2 2026 | $340M | +109% |
| Q1 2026 | -$161M | -$136M |
| Q4 2025 | $426M | +52% |
| Q3 2025 | $152M | +390% |
| Q2 2025 | $163M | -12% |
| Q1 2025 | -$25M | -$7M |
| Q4 2024 | $281M | -4.4% |
ALV has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
ALV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.8% | -1.3M shares |
| 1 year | -5% | -3.8M shares |
| 3 years | -14% | -12.1M shares |
| 5 years | -17% | -14.8M shares |
| Available history | -17% | -14.5M shares |
ALV has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $150M |
| Q2 2026 | $200M |
| Q1 2026 | — |
| Q4 2025 | $150M |
| Q3 2025 | $100M |
| Q2 2025 | $51M |
| Q1 2025 | $50M |
| Q4 2024 | $102M |
ALV spent $500M buying back its own shares over the past year, up 65% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
ALV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.0x | Healthy |
| Q3 2025 | 1.2x | Healthy |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.2x | Healthy |
ALV's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ALV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.3 | Neutral |
| Stochastic | 64.1 | Neutral |
ALV's weekly RSI is 50 (neutral) and its Stochastic is 64 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ALV PE vs Consumer Cyclical Sector
| Metric | ALV | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 18x | 21% below |
| PE % | 38 | 47 | 9 pts below |
ALV is trading at 14x earnings, a 21% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
ALV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $116.2 | 2.3% above |
| 20 week MA | $119.1 | 0.2% below |
| 50 week MA | $118.8 | 0% above |
| 100 week MA | $112.6 | 5.5% above |
| 200 week MA | $106.5 | 12% above |
ALV has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
ALV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $85.7 | $92.6 | +8% |
| 2021 | $92.6 | $101.1 | +9.2% |
| 2022 | $101.1 | $74.6 | -26% |
| 2023 | $74.6 | $110.2 | +48% |
| 2024 | $110.2 | $94.4 | -14% |
| 2025 | $94.4 | $120.4 | +28% |
| 2026 YTD | $120.4 | $118.9 | -1.3% |
ALV has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.